KT-301 for Chronic Kidney Disease Stage IV
(CKD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing KT-301, a live bacteria treatment, on patients with CKD Stage IV. The goal is to see if it can improve gut health and reduce harmful blood toxins and inflammation.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on probiotic supplements, immunosuppressant medications for immune-related kidney diseases, or anticoagulant medicines. It's best to discuss your specific medications with the trial team.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive KT-301 or placebo orally at 2 capsules per day for six months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- KT-301 (formerly US-APR2020)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kibow Pharma
Lead Sponsor